PagerDuty's stock jumps on strong earnings, sales
PagerDuty Inc.'s (PD) stock initially jumped 8% in extended trading Thursday after the enterprise-software company reported quarterly results that edged analyst revenue and earnings estimates. PagerDuty reported a fiscal-third-quarter net loss of $13.1 million, or 16 cents a share, compared with a net loss of $32.8 million, or 36 cents a share, in the same quarter a year ago. Adjusted earnings were 20 cents a share. Revenue was $108.7 million, up 15% from $94.2 million in the same quarter a year ago. Analysts surveyed by FactSet had expected on average net earnings of 14 cents a share on revenue of $107.7 million. "This has been a challenging environment, with customers cautious toward renewals," PagerDuty Chief Financial Officer Howard Wilson said in an interview. "But we excelled in customer acquisitions and expansion with more multiyear deals." For the fourth quarter, the company expects revenue of between $109.5 million and $111.5 million. FactSet analysts are forecasting $110.9 million. Shares of PagerDuty have tumbled 18% this year, while the broader S&P 500 index has increased 19%.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-30-23 1616ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise